latest news on semaglutide January 2026: New or Expanded Approvals for: GLP-1 Weight Loss, Birth Control Implant, Lung Disease, Menkes, Gaucher; Omeprazole Research and Case Studies; Rx-OTC Switches; Medication Tips Wegovy rolls out once-daily weight

Who wants to be on insulin if you have type 2 diabetes

GLP-1s just prove people dont want to work for it. Nope

Changes to your behavior, neuroendocrine, and autonomic responses also occur

Primary endpoint: change in body weight

The FDA highlights potential side effects of semaglutide that include nausea, diarrhea, vomiting, headache, and fatigue, and highlights that patients should discuss with their healthcare professional if they have symptoms of pancreatitis or gallstones (among other conditions) before starting treatment

MeAgain helps you remember what actually happened in your routine when you took your medication, what dose it was, and what side effects followed so you can have clearer conversations with your licensed clinician